NCT03187912View on ClinicalTrials.gov

Accelerated Corneal Cross-linking With Different Riboflavin Solutions

PHASE3CompletedINTERVENTIONAL
Enrollment

60

Participants

Timeline

Start Date

September 19, 2016

Primary Completion Date

March 30, 2020

Study Completion Date

March 30, 2020

Conditions
Keratoconus
Interventions
DRUG

Riboflavin

Riboflavin with 20% Dextran or HPMC will be admininstered every 2 minutes for overall 30 minuts (Dextran) or 10 minutes (HPMC), respectively

Trial Locations (1)

1090

Medical University of Vienna, Department of Ophthalmology, Vienna

All Listed Sponsors
lead

Medical University of Vienna

OTHER

NCT03187912 - Accelerated Corneal Cross-linking With Different Riboflavin Solutions | Biotech Hunter | Biotech Hunter